Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Janssen’s Phase 1 Results for Teclistamab Suggest Deep, Durable Responses

americanpharmaceuticalreviewMay 28, 2021

Tag: Janssen , Teclistamab , ASCO

PharmaSources Customer Service